Autologous Neo-Kidney Augment

· Tengion

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Autologous Neo-Kidney Augment, covering 2014-12-11 to 2021-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD) [Phase 2]